Free Trial

Bayer Aktiengesellschaft (ETR:BAYN) Hits New 12-Month Low - Here's Why

Bayer Aktiengesellschaft logo with Medical background

Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) shares reached a new 52-week low during trading on Monday . The stock traded as low as €24.72 ($26.87) and last traded at €24.75 ($26.90), with a volume of 2022884 shares changing hands. The stock had previously closed at €25.10 ($27.28).

Bayer Aktiengesellschaft Stock Down 1.4 %

The business has a 50-day simple moving average of €27.60 and a two-hundred day simple moving average of €27.37. The company has a market capitalization of $24.31 billion, a price-to-earnings ratio of -19.46, a PEG ratio of 36.39 and a beta of 0.97. The company has a debt-to-equity ratio of 129.94, a quick ratio of 0.72 and a current ratio of 1.27.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Bayer Aktiengesellschaft right now?

Before you consider Bayer Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.

While Bayer Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

MarketBeat analyst Thomas Hughes breaks down the biggest winners of the day, including Tesla, JP Morgan, and the Russell 2000, and why they’re surging.

Related Videos

Tesla Stock Rockets 15% Post-Earnings
Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines